Benzinga | Aug 6, 2020 09:26AM EDT

Pacira BioSciences Earlier Reported Q2 EPS $0.12 Beats $0.09 Estimate, Sales $75.50M Beat $72.46M Estimate

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.09 by 33.33 percent. This is a 70.73 percent decrease over earnings of $0.41 per share from the same period last year. The company reported quarterly sales of $75.50 million which beat the analyst consensus estimate of $72.46 million by 4.20 percent. This is a 26.41 percent decrease over sales of $102.60 million the same period last year.